PMV Pharmaceuticals
North America, California, United States, Redwood City
Description
PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.
Investor Profile
PMV Pharmaceuticals has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A rounds (top funding stages).
- Majority of deals are located in United Kingdom, The Netherlands.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (50%)
- Series A (50%)
Country Focus
- United Kingdom (50%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- The Netherlands (50%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
